Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VVOS | US
0.08
3.29%
Healthcare
Medical Devices
30/06/2024
04/10/2024
2.51
2.59
2.61
2.50
Vivos Therapeutics Inc. a medical technology company develops and commercializes treatment alternatives for patients with dentofacial abnormalities obstructive sleep apnea (OSA) and snoring in adults. It offers The Vivos Method a non-invasive non-surgical non-pharmaceutical multi-disciplinary treatment modality for the treatment of dentofacial abnormalities OSA and snoring. The company also offers VivoScore Program a screening and home sleep test in adults and children. It markets and sells its appliances and related treatments and services to licensed professionals primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton Colorado.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
85.6%1 month
199.1%3 months
138.3%6 months
118.2%-
-
2.03
0.28
0.11
-0.21
0.55
-
-12.90M
11.96M
11.96M
-
-47.76
-
19.40
-284.96
1.05
1.91
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.96
Range1M
3.56
Range3M
3.98
Rel. volume
0.02
Price X volume
194.57K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Innovative Eyewear Inc. | LUCY | Medical Instruments & Supplies | 8.19 | 12.86M | -7.98% | n/a | 0.00% |
PAVmed Inc | PAVM | Medical Devices | 1.27 | 12.64M | 1.60% | n/a | -67.66% |
GCTK | GCTK | Medical Instruments & Supplies | 2.1586 | 11.83M | -4.02% | n/a | -8.33% |
STRATA Skin Sciences Inc | SSKN | Medical Instruments & Supplies | 2.63 | 10.97M | -2.95% | n/a | 173.86% |
NeuroMetrix Inc | NURO | Medical Instruments & Supplies | 4.1384 | 8.38M | -1.47% | n/a | 1.02% |
Nexalin Technology Inc. | NXL | Medical Devices | 0.6579 | 6.96M | 5.45% | n/a | 0.00% |
INBS | INBS | Medical Devices | 1.59 | 6.76M | 1.92% | n/a | 10.46% |
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Predictive Oncology Inc | POAI | Medical Instruments & Supplies | 0.6434 | 4.29M | -11.63% | n/a | 65.94% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ohmyhome Limited Ordinary Shares | OMH | Real Estate Services | 0.4699 | 10.71M | 3.94% | n/a | 22.77% |
MDJM Ltd | MDJH | Real Estate Services | 0.657 | 10.51M | 1.56% | n/a | 0.00% |
LuxUrban Hotels Inc. | LUXH | Real Estate Services | 0.0767 | 10.50M | 3.09% | n/a | -387.21% |
La Rosa Holdings Corp. Common Stock | LRHC | Real Estate Services | 0.606 | 10.40M | -3.81% | n/a | 76.18% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
ALBT | ALBT | Real Estate Services | 0.2137 | 3.42M | 6.85% | n/a | 187.39% |
DigitalBridge Group Inc. | DBRG-PJ | Real Estate Services | 25.2 | 0 | 0.20% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PI | Real Estate Services | 25.45 | 0 | 0.24% | n/a | 17.23% |
DigitalBridge Group Inc. | DBRG-PH | Real Estate Services | 25.35 | 0 | 0.00% | n/a | 17.23% |
Common Stock | BPYPO | Real Estate Services | 16.78 | 0 | 0.54% | 7.55 | 866.10% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.21 | 45.99 | Cheaper |
Ent. to Revenue | 0.55 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 2.03 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 138.33 | 66.08 | Riskier |
Debt to Equity | 0.28 | 0.83 | Cheaper |
Debt to Assets | 0.11 | 0.28 | Cheaper |
Market Cap | 11.96M | 9.42B | Emerging |